Information was received from a healthcare professional (hcp) via a clinical study regarding a patient receiving compounded baclofen via an implantable pump.
It was reported that during a pump refill, on (b)(6) 2021, a reservoir volume discrepancy was noted: irv - 13.
9 ml, arv ¿ 9 ml.
No associated signs or symptoms and no further diagnostics or interventions were noted.
On (b)(6) 2021, a reservoir volume discrepancy was noted: irv - 16.
8 ml, arv ¿ 17 ml , which was within normal limits.
It was indicated the event was related to the device or therapy.
No actions were taken and the issue resolved without sequelae on (b)(6) 2021.
|